Trademark: XOLREMDI
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for XOLREMDI
We do not have any records of a proof of use for XOLREMDI at this moment.
Possible trademark infringements of XOLREMDI
Basic Information about XOLREMDI
- Serial Number
- 90476808
- Filing Date
- 20 Jan 2021
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of XOLREMDI on the blockchain with WikiTrademarks.io.
- First use of XOLREMDI anywhere
- XOLREMDI was first used on 30 Apr 2024 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns XOLREMDI?
1. X4 Pharmaceuticals, Inc. Boston MA
2. X4 Pharmaceuticals, Inc. Boston MA
Correspondent
- Sarah Anne Keefe WOMBLE BOND DICKINSON (US) LLP
- 470 ATLANTIC AVE.
- BOSTON, MA 02210-2228
- United States
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io